首页 | 本学科首页   官方微博 | 高级检索  
     

两种工艺制备的参芪扶正注射液对荷S180小鼠细胞免疫功能的影响
引用本文:丁治国,史晓光,李兰芳,汪唐顺,陈振宙,杨庆,张建松,叶广铎,崔巍,刘福鼎,李乃卿. 两种工艺制备的参芪扶正注射液对荷S180小鼠细胞免疫功能的影响[J]. 中国实验方剂学杂志, 2008, 14(12): 65-67
作者姓名:丁治国  史晓光  李兰芳  汪唐顺  陈振宙  杨庆  张建松  叶广铎  崔巍  刘福鼎  李乃卿
作者单位:1. 北京中医药大学东直门医院,北京,100700
2. 中国中医科学院中药研究所,北京,100700
基金项目:教育部产学研综合项目 
摘    要:目的:比较两种工艺制备的参芪扶正注射液对荷S180小鼠细胞免疫功能的影响。方法:将42只荷瘤小鼠随机分成5组,分别为对照组、现工艺制备的参芪扶正注射液高剂量组(8g·kg-1)和临床等效剂量组(4g·kg-1)、原工艺制备的参芪扶正注射液高剂量组(8g·kg-1)和临床等效剂量组(4g·kg-1)。腹腔注射给药,1次/d,实验组给予不同剂量的相应参芪扶正注射液,对照组给予生理盐水。7d后从小鼠眼眶后静脉丛取血进行全血细胞检测及T淋巴细胞亚群检测。结果:4个实验组白细胞和淋巴细胞总数皆高于对照组,其中现工艺4g·kg-1组与对照组的差异有统计学意义(P<0.01);4g·kg-1剂量组中,现工艺淋巴细胞总数显著高于原工艺(P<0.05);现工艺4g·kg-1组的CD4+淋巴细胞比例显著高于对照组(P<0.05);同一剂量两种工艺制剂之间T淋巴细胞亚群比例无显著差异。结论:在临床等效剂量上,现工艺制备的参芪扶正注射液可提高荷S180小鼠白细胞、淋巴细胞及CD4+T细胞的水平,效果优于或等于原工艺。

关 键 词:参芪扶正注射液  制备工艺  S180细胞  细胞免疫
收稿时间:2008-07-31

Effects of Shenqi Fuzheng Injections Prepared by Two Different Crafts on the Cellular Immune Function in S180-bearing Mice
DING Zhi-guo,SHI Xiao-guang,LI Lan-fang,WANG Tang-shun,CHEN Zhen-zhou,YANG Qing,ZHANG Jian-song,YE Guang-duo,CUI Wei,LIU Fu-ding,LI Nai-qing. Effects of Shenqi Fuzheng Injections Prepared by Two Different Crafts on the Cellular Immune Function in S180-bearing Mice[J]. China Journal of Experimental Traditional Medical Formulae, 2008, 14(12): 65-67
Authors:DING Zhi-guo  SHI Xiao-guang  LI Lan-fang  WANG Tang-shun  CHEN Zhen-zhou  YANG Qing  ZHANG Jian-song  YE Guang-duo  CUI Wei  LIU Fu-ding  LI Nai-qing
Affiliation:1.Dong Zhi Men Hospital,Beijing University of Chinese Medicine,Beijing 100700,China;2.Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China
Abstract:Objective:To compare effects of Shenqi Fuzheng Injections prepared by two different crafts on the cellular immune function in S180-bearing Mice.Methods: 42 tumor-bearing mice randomly divided into five groups:the model group,the high dose group(8 g·kg-1) and the clinical equivalent dose group(4 g·kg-1) of Shenqi Fuzheng Injection on current craft,the high dose group(8 g·kg-1) and the clinical equivalent dose group(4 g·kg-1) of Shenqi Fuzheng injection on previous craft.The model group was given physiological saline by intraperitoneal injection once a day,while the other groups was given different Shenqi Fuzheng Injections in the same way.7 days later,blood sample was taken from the vena orbitalis posterior of the mice and blood count and the subpopulation of T lymphocyte were determined.Results: The counts of the white blood cell and lymphocyte in four Shenqi Fuzheng Injection groups were higher than the model group,and the difference between the 4 g·kg-1 group of Shenqi Fuzheng Injection on current craft and the model group was very significant(P<0.01),and in the 4 g·kg-1 groups,the count of lymphocyte in the current craft group was significantly higher than the previous one(P<0.05).The ratio of CD4+ T lymphocyte in the 4 g·kg-1 group on current craft was significantly higher than the model one(P<0.05).There was no significant difference between the ratio of the subpopulation of T lymphocyte on the current craft and the previous one at the same dose.Conclusion: In clinical equivalent dose(4 g·kg-1),the Shenqi Fuzheng Injection prepared by the current craft could enhance the counts of the white blood cell and lymphocyte and the radio of CD4+ T lymphocyte,and the effectiveness was better than or equal to the previous craft.
Keywords:Shenqi Fuzheng Injection  crafts  S180 cells  cellular immune function
本文献已被 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号